Cargando…
Obesity-Linked PPARγ Ser273 Phosphorylation Promotes Beneficial Effects on the Liver, despite Reduced Insulin Sensitivity in Mice
Since the removal of thiazolidinediones (TZDs) from the market, researchers have been exploring alternative anti-diabetic drugs that target PPARγ without causing adverse effects while promoting insulin sensitization by blocking serine 273 phosphorylation (Ser273 or S273). Nonetheless, the underlying...
Autores principales: | Terra, Maiara Ferreira, García-Arévalo, Marta, Avelino, Thayná Mendonça, Degaki, Karina Y., de Carvalho, Murilo, Torres, Felipe Rafael, Saito, Angela, Figueira, Ana Carolina Migliorini |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10135908/ https://www.ncbi.nlm.nih.gov/pubmed/37189379 http://dx.doi.org/10.3390/biom13040632 |
Ejemplares similares
-
AM-879, a PPARy non-agonist and Ser273 phosphorylation blocker, promotes insulin sensitivity without adverse effects in mice
por: Terra, M.F., et al.
Publicado: (2022) -
PPARγ S273 Phosphorylation Modifies the Dynamics of Coregulator Proteins Recruitment
por: Dias, Marieli Mariano Gonçalves, et al.
Publicado: (2020) -
3-Hydroxybutyrate ameliorates insulin resistance by inhibiting PPARγ Ser273 phosphorylation in type 2 diabetic mice
por: Zhang, Yudian, et al.
Publicado: (2023) -
PPM1A Controls Diabetic Gene Programming through Directly Dephosphorylating PPARγ at Ser273
por: Khim, Keon Woo, et al.
Publicado: (2020) -
DHA increases adiponectin expression more effectively than EPA at relative low concentrations by regulating PPARγ and its phosphorylation at Ser273 in 3T3-L1 adipocytes
por: Song, Jia, et al.
Publicado: (2017)